PharmaPoint: Insomnia-Global Drug Forecast and Market Analysis to 2023
Single User License - $10995 Site User License - $21990 Corporate User License - $32985 Publication Date - Feb 2015 Pages - 379 To know more details, email to debora@reportstack.com
Contact: debora@reportstack.com Reportstack Market Research
Summary ď ś Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patientreported difficultly with sleep initiation or sleep maintenance which can include frequent awakenings, difficulty returning to sleep after awakenings, or awakening too early with inability to return to sleep. Cases of insomnia can be classified on the basis of etiology into primary and secondary (or comorbid) subtypes. The insomnia market is widely genericized creating a competitive environment for new products. As such, the treatment algorithm centers on the generically available nonbenzodiazepines and lowdose sedating antidepressants, despite the launch of numerous novel agents.
Contact: debora@reportstack.com Reportstack Market Research
Scope • Overview of insomnia, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines. • Annualized insomnia market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023. • Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the insomnia therapeutics market.
Contact: debora@reportstack.com Reportstack Market Research
Key Benefits • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list. • Develop business strategies by understanding the trends shaping and driving the global insomnia therapeutics market. • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global insomnia therapeutics market in future.
Contact: debora@reportstack.com Reportstack Market Research
Companies Mentioned • • • • • • • • • • • • •
Sanofi Sunovion Dainippon Sumitomo Pfizer Takeda Meda Eisai Purdue Neurim Pernix Therapeutics Merck & Co. ECR Pharmaceuticals Astellas, etc.
Contact: debora@reportstack.com Reportstack Market Research
If you are interested...
Contact : Debora White Email: debora@reportstack.com Ph:+1-888-789-6604 http://www.reportstack.com
Contact: debora@reportstack.com Reportstack Market Research